{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"\ud83d\udcca MRI. NT-proBNP. Outcomes: A New Roadmap for HCM Care","description":"\ud83e\udec0 Scar. Signal. Survival. &amp;nbsp; A major new JAMA study from the NHLBI Hypertrophic Cardiomyopathy Registry followed 2,698 patients for nearly 7 years and demonstrated that advanced cardiac magnetic resonance imaging and NT-proBNP markedly improve prediction of adverse outcomes in hypertrophic cardiomyopathy. &amp;nbsp; \ud83d\udccc Key findings: \u2022 Late gadolinium enhancement (fibrosis burden) strongly predicted events \u2022 LGE \u22659% of LV mass substantially increased risk \u2022 LV mass index, LV systolic dysfunction, and NT-proBNP independently predicted outcomes \u2022 Traditional markers alone may miss important risk signals &amp;nbsp; This work moves HCM risk assessment beyond simple wall thickness toward a multidimensional precision cardiology approach. &amp;nbsp; \ud83d\udcd6 JAMA. Published online May 11, 2026. #Cardiology #HCM #HypertrophicCardiomyopathy #CardiacMRI #CMR #HeartFailure #SuddenCardiacDeath #PrecisionMedicine #CardioTwitter #JAMA ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41315335\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202009250"}